A phase II, randomized, double-blind, placebo-controlled study of NBI-56418 in endometriosis.
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Elagolix (Primary)
- Indications Endometriosis; Pelvic pain
- Focus Therapeutic Use
- 21 Feb 2012 Abbott as trial company, lead trial centre and lead investigator (Laura Williams) added as reported by ClinicalTrials.gov.
- 03 Oct 2005 New trial record.